Abstract
KR-31378 is a new drug candidate intended for the use in the prevention of ischemia-reperfusion damage. The objective of this preformulation study was to determine the physicochemical properties of KR-31378. The η-octanol to water partition coefficients of KR-31378 were 0.0504 at pH 3 and 0.8874 at pH 10. Accelerated stability of KR-31378 in solution and solid state was studied at 5, 40, 60°C. The stability testing indicated that thet90 for the drug in solid was estimated to be 2 years and 128.6 days at 25°C, while the that in aquesou solution was 68.6 days at 25°C. The KR-31378 was also found to be unstable under the relative humidity of 76%, probably because of the hygroscopic nature of the drug. In order to study compatibility of KR-31378 with typical excipients, potential change in differential scanning calorimetry spectrum was studied in 1:1 binary mixtures of KR-31378 and Aerosil, Avicel, Eudragit, lactose, PEG, talc, CMC, PVP, starch. As a result, CMC, PVP, and starch were found to be incompatible with KR-31378, indicating the addition of these excipients may complicate the manufacturing of the formulation for the drug. Particle size distribution of KR-31378 powder was in the size range of 9–93 μm with the mean particle size of 37.9 μm. The flowability of KR-31378 was apparently inadequate, indicating the granulation may be necessary for the processing of the drug to solid dosage forms. Crystallization of the drug with a number of organic solvents did not lead a crystalline polymorphism. In addition, dissolution of the drug from the powder was adequately rapid at 37ΰC in water.
Similar content being viewed by others
References
Aulton, M. E., Pharmaceutics, second edition, pp. 113–138, Churchill Livingstone, Edinburgh (2002).
Botha, S. A. and Lotter, A. P., Compatibility study between ketoprofen and tablet excipients using differential scanning calorimetry.Drug Devel. Ind. Pharm., 15, 415–426 (1989).
Haleblian, J. and McCrone, W., Pharmaceutical applications of polymorphism.J. Pharm. Sci., 58, 911–929 (1969).
Holgado, M. A., Fernandez-Arevalo, M., Gines, J. M., Caraballo, I., and Labasco, A. M., Compatibility study between carteolol hydrochloride and tablet excipients using differential scanning calorimetry and hot stage microscopy.Pharmazie, 50, 195–198 (1995).
Hong, K. W., Kim, K. Y., Lee, J. H., Shin, H. K., Kwak, Y. G., Kim, S. O., Lim, H., and Yoo, S. E., Neuroprotective effect of (2S,3S,4R)-N”-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N-benzyl-guanidine (KR-31378), a benzopyran analog, against focal ischemic brain damage in rats.J. Phamacol. Exp. Ther., 301, 210–216 (2002).
Lachman, L., Lieberman, H. A., and Kanig, J. L.,The theory and practice of industrial pharmacy, pp 171–196, Lea & Febiger, Philadelphia, (1986).
Lee, B. H., Seo, H. W., Yoo, S-E., Kim, S-O., Lim, H., and Shin, H. S., Differential action of KR-31378, a novel potassium Channel activator, on cardioprotective and hemodynamic effects.Drug Development Res., 54, 182–190 (2001).
Rivera, A. B. and Hernandez, R. G., Physico-chemical and solid-state characterization of secnidazole.II Farmaco, 55, 700 (2002).
Sohn, Y. T. and Lee, A. K., Compatibility study using differential scanning calorimetry.J. Kor. Pharm. Sci., 29, 117–126 (1999).
Sohn, Y. T., Lee, J. K. and Im, W. B., Polymorphism of clarithromycin.Arch. Pharm. Res., 23, 381–384 (2000).
Yoo, S-E., Yi, K. Y., Lee, S., Suh, J., Kim, N., Lee, B. H., Seo, H. W., Kim, S-O., Lee, D. H., Lim, H., and Shin, H. S., A novel anti-ischemic ATP-sensitive potassium channel(KATP)opener without vasorelaxation:N-(6-aminobenzopyranyl)-N-benzyl-N’-cyanoguanidine analogue.J. Med. Chem., 44, 4207–4215 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sohn, Y.T., Park, B.Y. Characterization of the physicochemical properties of KR-31378. Arch Pharm Res 26, 526–531 (2003). https://doi.org/10.1007/BF02976875
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976875